Default Category
-
Industry Canada: The Knowledge Infrastructure Program
Paul Boothe; Omar FayoumiCase IVEY-9B14M163-EStrategyIn late January 2009, the assistant deputy minister of Industry Canada was considering how to design the Knowledge Infrastructure Program, which had unexpectedly been assigned to the department in the recent federal budget. A $2 billion spending program focused on knowledge infrastructure, its projects were required to be completed within two years. The immediate goals were to provide a significant short-term economic stimulus and help create job...Starting at €8.20
-
Beyond the Border
Paul BootheCase IVEY-9B14M009-EStrategyIn February 2011, the senior associate deputy minister of Industry Canada was appointed as the Canadian prime minister’s personal representative to the bi-national team charged with developing the “Beyond the Border Action Plan” to both improve security and streamline cross-border commerce and travel between Canada and the United States. He was immediately faced with a range of decisions on how to proceed — whom to consult, which Canadian team me...Starting at €8.20
-
Environment Canada
Paul BootheCase IVEY-9B14M011-EStrategyIn late January 2011, the assistant deputy minister of Environment Canada is contemplating the final report of the joint review panel conducting the environmental assessment of Total E&P Canada’s $10 billion oil sands project, the Joslyn Mine near Fort McMurray, Alberta. Although the report advised that the project would be in the public interest only if — and it was a big if — adverse effects on species at risk were fully mitigated, she was awar...Starting at €8.20
-
Ontario Power Generation
Paul BootheCase IVEY-9B14M012-EStrategyIn late December 2003, the new acting CEO of Ontario Power Generation, the provincial Crown corporation responsible for the bulk of the province’s electrical power generation, was deeply worried. Three major events had led to a decline in the company’s revenues in 2003: a massive power failure that affected large portions of Ontario and the U.S. eastern seaboard in August, the maintenance-related planned outage at the Darlington Nuclear Station a...Starting at €8.20
-
U.S. Healthcare Reform: Reaction to the Patient Protection and Affordable Care Act of 2010
Daemmrich, Arthur A.Case HBS-711103-EEconomicsSupplement to "U.S. Healthcare Reform: International Perspectives," HBS No. 710-040, updating key events and disputes concerning the reform law, including the 2010 Congressional elections, legislative proposals, legal challenges, and responses by employers.Starting at €8.20
-
Devonian Coast Wineries: Overcoming Provincial Barriers
W. Glenn Rowe; Paul Boothe; Ken MarkCase IVEY-9B16M111-EEntrepreneurship, StrategyBy late 2015, the chief executive officer of Devonian Coast Wineries in the Canadian province of Nova Scotia had invested in the business and had broadened the distribution of the wines he produced. His chief concern was growing sales beyond Nova Scotia’s provincial borders. Selling wines in other provinces was difficult because it required approaching the various provincial liquor control boards. He had three options: continue to engage with eac...Starting at €8.20
-
Telesat Canada
Paul Boothe; Connor LyonsCase IVEY-9B14M164-EStrategyIn June 2007, the chief executive officer of Telesat Canada, headquartered in Ottawa, Ontario, was considering his strategy following a decision by Industry Canada to reject four out of six of its applications for satellite slots. His largest concern was the decision to award the two most important licences for the Extended Ku-band network — which the company’s largest clients, Bell Canada Inc. and Shaw Communications, were both seeking — to a su...Starting at €8.20
-
A Managerial Perspective on Clinical Trials
Daemmrich, Arthur A.Case HBS-709033-EEntrepreneurshipThis note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70 percent of a drug's total development costs, pharmaceutical and biotechnology leaders need to understand clinical trial management. Likewise, with a growing variety of new product i...Starting at €8.20
-
Targanta Therapeutics: Hitting a Moving Target, Teaching Note
Daemmrich, Arthur A.Teaching Note HBS-710006-EEntrepreneurshipTeaching Note for [709002].Starting at €0.00
-
Arcadia Biosciences: Seeds of Change (Abridged)
Daemmrich, Arthur A.Case HBS-711050-EArcadia Biosciences is seeking to introduce genetically modified rice to China that will lower farmers' costs and generate environmental benefits through reduced greenhouse gas emissions. The case describes challenges facing this small agricultural biotechnology company, notably uneven enforcement of intellectual property in emerging market countries, and uncertainty regarding the provision and market value of carbon credits under international c...Starting at €8.20